NCT05107908 Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
| NCT ID | NCT05107908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Overweight and Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 228 participants |
| Start Date | 2021-11-12 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 228 participants in total. It began in 2021-11-12 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine how different behavioral interventions designed to alter food perceptions and behaviors affect brain responses to food, eating behaviors, and body weight.
Eligibility Criteria
Inclusion Criteria: * 18-65 years old * BMI of 27 or greater Exclusion Criteria: * MRI contraindications (e.g., metal or electronic devices in the body) * Pregnancy
Contact & Investigator
Jason Tregellas, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT05107908 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Overweight and Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05107908 currently recruiting?
Yes, NCT05107908 is actively recruiting participants. Contact the research team at christina.erpelding@cuanschutz.edu for enrollment information.
Where is the NCT05107908 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT05107908 clinical trial?
NCT05107908 is sponsored by University of Colorado, Denver. The principal investigator is Jason Tregellas, PhD at University of Colorado, Denver. The trial plans to enroll 228 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.